Ng George K 4

What Happened
George K. Ng, CEO of Processa Pharmaceuticals, purchased 3,057 shares on July 1, 2026 at $1.93 per share, a total cost of approximately $5,900. The transaction is reported as a purchase (code P) — a direct buy rather than a sale.

Key Details

• Transaction date and price: July 1, 2026 — 3,057 shares at $1.93 each.
• Total value: ≈ $5,900 (3,057 × $1.93 = $5,900.01).
• Transaction type: Purchase (P) — reported as an open-market or private purchase.
• Shares owned after transaction: Not specified in the information provided on the filing.
• Filing timeliness: Reported on July 1, 2026 (filed the same day); no late-filing indication in this record.
• No footnotes (e.g., 10b5-1 plan or tax withholding) were noted in the summary information provided.

Context
Insider purchases can be interpreted as a mild positive signal since an executive is adding shares, but this is a relatively small-dollar buy (~$5.9k). This filing is a routine disclosure of the transaction; it does not by itself explain the CEO’s motivation.